In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients : the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.

Nyckelord

Aged

Aged; 80 and over

Antihypertensive Agents/therapeutic use

Atenolol/therapeutic use

Blood Pressure/drug effects

Comorbidity

Diabetes Mellitus/diagnosis/epidemiology/*prevention & control

Electrocardiography

Female

Follow-Up Studies

Humans

Hypertension/*drug therapy/epidemiology

Hypertrophy; Left Ventricular/diagnosis/*drug therapy/epidemiology

Incidence

Losartan/*therapeutic use

Male

Middle Aged

Proportional Hazards Models

Randomized Controlled Trials as Topic/statistics & numerical data

Risk Factors

Treatment Outcome

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)